Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
FDA chooses not to approve new nasal spray for heart rhythm issues
Etripamil's journey toward FDA approval hit a roadblock. The agency requested additional information on the drug, including a new facility inspection, in a response letter sent to Milestone Pharmaceuticals.
Abbott gains CE mark approval for Volt PFA system
The approval, which Abbott said arrived earlier than expected, came after regulators reviewed data from a 2024 clinical trial.
Enabling X-ray-free ablation procedures in the EP lab
Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.
The evolution of RF technology to reduce complications and improve outcomes
Advancements in radiofrequency (RF) catheter ablation technology have been incremental over the past 30 years in efforts to improve safety, procedural efficiency and patient outcomes. While some newer technologies have gained a lot of attention in electrophysiology (EP) over the past several years, RF remains the solid frontline treatment.

Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology

Waldo was a founding member of the North American Society of Pacing and Electrophysiology, which is now known as the Heart Rhythm Society, and was revered for his helpfulness and kindness.

device implantation during left atrial appendage occlusion (LAAO) procedures

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

FDA clears 2 new AI models that help with the diagnosis and treatment of arrhythmias

The two algorithms are now commercially available on a price-per-use basis.

FDA highlights importance of including heart rhythm risks on drug labels

The agency has shared a new draft guidance focused on the inclusion of information related to QTc interval prolongation.

Boston Scientific’s POLARx Cryoablation System for atrial fibrillation gained FDA approval in August 2023.

FDA approves Boston Scientific’s new cryoablation system for AFib

The system includes an expandable cryoablation balloon catheter compatible with multiple balloon sizes.

NFL player feeling thankful after AFib diagnosis: ‘I think it’s just the good Lord looking after me’

Tyler Shatley, a veteran offensive lineman with the Jacksonville Jaguars, said he experienced symptoms for years before finally seeking a diagnosis.

The ThermoCool SmartTouch SF catheter from Biosense Webster

FDA approves several Biosense Webster devices for fluoroscopy-free ablation procedures

Using these devices as part of a zero-fluoroscopy workflow, which replaces X-rays with an alternative modality such as ultrasound, limits radiation exposure and the use of burdensome protective equipment.

Electrophysiology

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

FDA chooses not to approve new nasal spray for heart rhythm issues

Abbott gains CE mark approval for Volt PFA system

Enabling X-ray-free ablation procedures in the EP lab

The evolution of RF technology to reduce complications and improve outcomes